KAI Pharmaceuticals Business Development Manager Salaries in Baltimore, MD
The average KAI Pharmaceuticals Business Development Manager in Baltimore, MD earns an estimated $154,697 annually, which includes an estimated base salary of $137,697 with a $17,000 bonus. KAI Pharmaceuticals' Business Development Manager compensation is $22,556 more than the US average for a Business Development Manager. Business Development Manager salaries at KAI Pharmaceuticals in Baltimore, MD can range from $79,000 - $243,000.
In Baltimore, MD, The Business Development Department at KAI Pharmaceuticals earns $9,915 more on average than the Finance Department.
Last updated 5 years ago.
- $137,697
- avg. base
- $17,000
- avg. bonus
Business Development Manager Salaries at KAI Pharmaceuticals
In Baltimore, MD, Business Development Managers earn $7,579 more than Business Development Managers, and $22,872 less than Directors of Business Development.
Compensation at KAI Pharmaceuticals by Department
In Baltimore, MD, The Business Development Department averages $9,915 more than the Finance Department, and $8,967 less than the IT Department
Business Development Manager Compensation by Gender (All Companies)
The average female Business Development Manager at companies similar size to KAI Pharmaceuticals reported making $151,865, while the average male Business Development Manager at similar sized companies reported making $160,499.
Business Development Manager Compensation by Ethnicity (All Companies)
The average Hispanic or Latino Business Development Manager at companies similar size to KAI Pharmaceuticals reported making $180,546, while the average African American/Black Business Development Manager at similar sized companies reported making $121,400.
How Business Development Managers at KAI Pharmaceuticals Rate Their Compensation
The majority of Business Development Managers at KAI Pharmaceuticals believe they're compensated fairly. 100% of Business Development Managers at KAI Pharmaceuticals say they receive annual bonuses, and the majority (50%) are satisfied with their benefits. See more compensation ratings at KAI Pharmaceuticals
